Loading...
276 A 4-Year Follow-up in Children With Moderate/Severe Asthma after Withdrawal 1 Year Omalizumab Treatment
BACKGROUND: Asthma guidelines include omalizumab in the step up management in those patients with severe non-controlled asthma despite the use of the inhaled corticosteroids (ICS) at the highest dose recommended and/or oral corticosteroids (OCS) courses. This communication describes the 4 year follo...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
World Allergy Organization Journal
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3512580/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.WOX.0000412033.47007.6f |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|